Clinical Course of Chronic Spontaneous Urticaria in the Korean Adult Population
- Authors
- Kim, Yoon Seob; Park, Sang Hyun; Han, Kyungdo; Lee, Ji Hyun; Kim, Nack In; Roh, Joo Young; Seo, Seong Jun; Song, Hae Jun; Lee, Min-Geol; Choi, Jee Ho; Park, Young Min
- Issue Date
- 1월-2018
- Publisher
- KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY
- Keywords
- Korea; urticarial; clinical course
- Citation
- ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, v.10, no.1, pp.83 - 87
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- ALLERGY ASTHMA & IMMUNOLOGY RESEARCH
- Volume
- 10
- Number
- 1
- Start Page
- 83
- End Page
- 87
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/78039
- DOI
- 10.4168/aair.2018.10.1.83
- ISSN
- 2092-7355
- Abstract
- Knowledge of the clinical course of chronic spontaneous urticaria (CSU) remains unclear. The purpose of our study was to investigate the clinical course of CSU in the Korean adult population. Each patient in the CSU group who was defined by disease codes between 2003 and 2007 was tracked whether he or she went into remission or not until 2013. Kaplan-Meier survival analysis was carried out to analyze remission, and log-rank tests were performed for between-group comparisons. Demographic differences between subjects who went into remission 1 year after the initial diagnosis and those who did not were analyzed using chi(2) tests. A total of 13,969 subjects were included in the CSU group. The 1-, 2-, 3-,4-, and 5-year remission rates of CSU were 21.5%, 33.0%, 38.9%, 42.6%, and 44.6%, respectively. The proportion of subjects in the 65+ age group (P=0.050) and with male gender (P=0.002) was significantly higher among subjects who did not go into remission 1 year after the initial diagnosis. Our study indicates that CSU could have a more persistent course than previously reported.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.